NEW HAVEN, Conn., June 11, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Milind Deshpande, Ph.D. has been promoted to Executive Vice President of Research. Dr. Deshpande previously served as the Company’s Senior Vice President, and retains his position as Chief Scientific Officer.
